GSDMB and bladder transitional cell carcinoma: Our research also indicated that GSDMB was highly expressed in BLCA and hyper-expression of GSDMB was associated with low risk, low-grade infiltration, early stage (I and II), no lymph node infiltration (N0), and no distant metastasis (M0) of BLCA patients, all p < 0.05.